Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Montejano, R; de la Calle-Prieto, F; Velasco, M; Guijarro, C; Queiruga-Parada, J; Jimenez-Gonzalez, M; Gonzalez-Ruano, P; Martinez, P; Goikoetxea, AJ; Ibarrola, M; Ciudad, M; Gutierrez, A; Torralba, M; Diaz-Brasero, A; Ryan, P; Marcelo, C; Diez, C; Ibarra, S; Merino, E; Estrada, V; Marcos, J; Novella, M; Rivera, MA; Ruiz-Munoz, M; de Miguel, M; Soler, L; Del Alamo, M; Moreno, S; Carcas, AJ; Borobia, AM; Arribas, JR.

Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial

CLINICAL INFECTIOUS DISEASES. 2022; 76(3): 116-125 Nº de citas: 17 [doi:10.1093/cid/ciac628]

Troya, J; Duenas, C; Irazola, I; de los Santos, I; de la Fuente, S; Gil, D; Hernandez, C; Galindo, MJ; Gomez, J; Delgado, E; Moreno-Garcia, E; Posada, G; Aldamiz, T; Iribarren, JA; Guerra, JM; Moran, MA; Galera, C; Fuente, J; Pelaez, A; Cervero, M; Garcinuno, M; Montero, M; Ceballos, F; Buzon, L.

Dolutegravir plus rilpivirine: benefits beyond viral suppression DORIPEX retrospective study

MEDICINE. 2022; 101(24): Nº de citas: 11 [doi:10.1097/MD.0000000000029252]

Cruz, R; Diz-de Almeida, S; de Heredia, ML; Quintela, I; Ceballos, FC; Lorenzo-Salazar, GM; Gonzalez-Montelongo, R; Gago-Dominguez, M; Porras, MS; Castano, JAT; Nevado, J; Aguado, JM; Aguilar, C; Aguilera-Albesa, S; Almadana, V; Almoguera, B; Alvarez, N; Andreu-Bernabeu, A; Arana-Arri, E; Arango, C; Arranz, MJ; Artiga, MJ; Baptista-Rosas, RC; Barreda-Sanchez, M; Belhassen-Garcia, M; Bezerra, JF; Bezerra, MAC; Boix-Palop, L; Brion, M; Brugada, R; Bustos, M; Calderon, EJ; Carbonell, C; Castano, L; Castelao, JE; Conde-Vicente, R; Cordero-Lorenzana, ML; Cortes-Sanchez, JL; Corton, M; Darnaude, MT; De Martino-Rodriguez, A; del Campo-Perez, V; de Bustamante, AD; Dominguez-Garrido, E; Luchessi, AD; Eiros, R; Sanabria, GME; Carmen Farinas, M; Fernandez-Robelo, U; Fernandez-Rodriguez, A; Fernandez-Villa, T; Gil-Fournier, B; Gomez-Arrue, J; Alvarez, BG; de Quiros, FGB; Gonzalez-Penas, J; Gutierrez-Bautista, JF; Herrero, MJ; Herrero-Gonzalez, A; Jimenez-Sousa, MA; Lattig, MC; Borja, AL; Lopez-Rodriguez, R; Mancebo, E; Martin-Lopez, C; Martin, V; Martinez-Nieto, O; Martinez-Lopez, I; Martinez-Resendez, MF; Martinez-Perez, A; Mazzeu, JF; Macias, EM; Minguez, P; Cuerda, VM; Silbiger, VN; Oliveira, SF; Ortega-Paino, E; Parellada, M; Paz-Artal, E; Santos, NPC; Perez-Matute, P; Perez, P; Perez-Tomas, ME; Perucho, T; Pinsach-Abuin, ML; Pompa-Mera, EN; Porras-Hurtado, GL; Pujol, A; Leon, SR; Resino, S; Fernandes, MR; Rodriguez-Ruiz, E; Rodriguez-Artalejo, F; Rodriguez-Garcia, JA; Cabello, FR; Ruiz-Hornillos, J; Ryan, P; Soria, JM; Souto, JC; Tamayo, E; Tamayo-Velasco, A; Taracido-Fernandez, JC; Teper, A; Torres-Tobar, L; Urioste, M; Valencia-Ramos, J; Yanez, Z; Zarate, R; Nakanishi, T; Pigazzini, S; Degenhardt, F; Butler-Laporte, G; Maya-Miles, D; Bujanda, L; Bouysran, Y; Palom, A; Ellinghaus, D; Martinez-Bueno, M; Rolker, S; Amitrano, S; Roade, L; Fava, F; Spinner, CD; Prati, D; Bernardo, D; Garcia, F; Darcis, G; Fernandez-Cadenas, I; Holter, JC; Banales, JM; Frithiof, R; Duga, S; Asselta, R; Pereira, AC; Romero-Gomez, M; Nafria-Jimenez, B; Hov, JR; Migeotte, I; Renieri, A; Planas, AM; Ludwig, KU; Buti, M; Rahmouni, S; Alarcon-Riquelme, ME; Schulte, EC; Franke, A; Karlsen, TH; Valenti, L; Zeberg, H; Richards, B; Ganna, A; Boada, M; de Rojas, I; Ruiz, A; Sanchez-Juan, P; Real, LM; Guillen-Navarro, E; Ayuso, C; Gonzalez-Neira, A; Riancho, JA; Rojas-Martinez, A; Flores, C; Lapunzina, P; Carracedo, A.

Novel genes and sex differences in COVID-19 severity

HUMAN MOLECULAR GENETICS. 2022; : 3789-3806 Nº de citas: 53 [doi:10.1093/hmg/ddac132]

Teira, R; Diaz-Cuervo, H; Aragao, F; Castano, M; Romero, A; Roca, B; Montero, M; Galindo, MJ; Munoz-Sanchez, MJ; Espinosa, N; Peraire, J; Martinez, E; De la Fuente, B; Domingo, P; Deig, E; Merino, MD; Geijo, P; Estrada, V; Sepulveda, MA; Garcia, J; Berenguer, J; Curran, A.

Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort

Infectious Diseases and Therapy. 2022; 11(3): 1177-1192 Nº de citas: 4 [doi:10.1007/s40121-022-00630-y]

Sepulveda-Crespo, D; Yelamos, MB; Diez, C; Gomez, J; Hontanon, V; Torresano-Felipe, F; Berenguer, J; Gonzalez-Garcia, J; Ibanez-Samaniego, L; Llop, E; Olveira, A; Martinez, J; Resino, S; Martinez, I.

Negative impact of HIV infection on broad-spectrum anti-HCV neutralizing antibody titers in HCV-infected patients with advanced HCV-related cirrhosis

BIOMEDICINE & PHARMACOTHERAPY. 2022; 150: Nº de citas: 4 [doi:10.1016/j.biopha.2022.113024]

Alejos, B; Diez, C; Galindo, MJ; Lopez, JC; Moreno-Garcia, E; Estrada, V; Poveda, E; Omar, M; Jarrin, I; Berenguer, J.

Progress in the quality of care for newly diagnosed people with HIV in Spain (2004-2019)

ANTIVIRAL THERAPY. 2022; 27(4): Nº de citas: 3 [doi:10.1177/13596535221112729]

Guembe, MG; Pensado, YT; Picado, FT; Diez, C; Latorre, LP; Fanciulli, C; Vazquez, FP; de Quiros, JCLB; Berenguer, J; Ortega, BP; Machado, M; Minero, MV; Garcia, PM; Santiago, EB; Galar, A; Catalan, P; Alonso, R; Bellon, JM; Lois, TAE; Gregorio Maranon Microbiology-ID.

SARS-COV-2 Infection in People Living with HIV: Experience from a Tertiary Hospital in Madrid

AIDS RESEARCH AND HUMAN RETROVIRUSES. 2022; 38(5): 394-398 Nº de citas: 4 [doi:10.1089/aid.2021.0159]

Suarez-Garcia, I; Ruiz-Alguero, M; Alejos, B; Garcia-Yubero, C; Belza, MJ; Espacio, R; Hernandez, J; Sanchez, JM; Garaialde, A; Socas, MDA; Alcaraz, A; de Galarreta, BPR; Madrid, OJM; Cuellar, IG; Gomez-Ayerbe, C; Olalla, J; Jarrin, I.

Brief Report: Patients' Experiences and Opinions After Desimplification of Their Single-Tablet Regimens for the Treatment of HIV Infection: A Survey in a Multicentre Cohort

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2022; 90(1): 62-68 Nº de citas: 3 [doi:10.1097/QAI.0000000000002923]

Carrasco, I; Olveira, A; Lancharro, A; Escosa, L; Mellado, MJ; Busca, C; Montes, ML; Diez, C; Alcolea-Ruiz, S; Navarro, ML; Sainz, T.

Prevalence of nonalcoholic fatty liver disease using noninvasive techniques among children, adolescents, and youths living with HIV

AIDS. 2022; 36(6): 805-814 Nº de citas: 13 [doi:10.1097/QAD.0000000000003170]

Serrano-Villar, S; Lopez-Huertas, MR; Jimenez, D; Galera, C; Martinez-Sanz, J; Moreno, E; Muriel, A; Gutierez, F; Busca, C; Portilla, J; Bisbal, O; Iribarren, JA; Tejerina, F; de los Santos, I; Moreno, S.

Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens

Frontiers in Immunology. 2022; 13: Nº de citas: 17 [doi:10.3389/fimmu.2022.848630]

Tejerina, F; Catalan, P; Rodriguez-Grande, C; Adan, J; Rodriguez-Gonzalez, C; Munoz, P; Aldamiz, T; Diez, C; Perez, L; Fanciulli, C; de Viedma, DG; Gregorio Maranon Microbiol ID COVI.

Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19

BMC INFECTIOUS DISEASES. 2022; 22(1): Nº de citas: 89 [doi:10.1186/s12879-022-07153-4]

Virseda-Berdices, A; Rojo, D; Martinez, I; Berenguer, J; Gonzalez-Garcia, J; Brochado-Kith, O; Fernandez-Rodriguez, A; Diez, C; Hontanon, V; Perez-Latorre, L; Mican, R; Barbas, C; Resino, S; Jimenez-Sousa, MA.

Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients

BIOMEDICINE & PHARMACOTHERAPY. 2022; 147: Nº de citas: 12 [doi:10.1016/j.biopha.2022.112623]

Lazarus JV; Villota-Rivas M; Fernández I; Gea F; Ryan P; López SA; Guy D; Calleja JL; García-Samaniego J.

A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid.

Communications Medicine. 2022; 2(1): 20-20 Nº de citas: 7 [doi:10.1038/s43856-022-00077-9]

Virseda-Berdices, A; Brochado-Kith, O; Diez, C; Hontanon, V; Berenguer, J; Gonzalez-Garcia, J; Rojo, D; Fernandez-Rodriguez, A; Ibanez-Samaniego, L; Llop-Herrera, E; Olveira, A; Perez-Latorre, L; Barbas, C; Rava, M; Resino, S; Jimenez-Sousa, MA.

Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(3): 719-726 Nº de citas: 12 [doi:10.1093/jac/dkab444]

Valencia, J; Lazarus, JV; Ceballos, FC; Troya, J; Cuevas, G; Resino, S; Torres-Macho, J; Ryan, P.

Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care

LIVER INTERNATIONAL. 2022; 42(2): 309-319 Nº de citas: 16 [doi:10.1111/liv.15095]

Conway, B; Rodriguez-Tajes, S; Garcia-Retortillo, M; Perez-Hernandez, P; Teti, E; Ryan, P; Fraser, C; Macedo, G; Amado, LEM; de Ledinghen, V; Fenech, M; Martins, A; Guerra-Veloz, MF; Ntalla, I; Ramroth, H; Vanstraelen, K; Hernandez, C; Mertens, M; O'Loan, J.

Real-world evidence of sofosbuvir/velpatasvir as an effective and simple hepatitis C virus treatment and elimination tool in homeless populations

Future Virology. 2022; 17(2): 77-86 Nº de citas: 3 [doi:10.2217/fvl-2021-0266]

Salto-Alejandre, S; Palacios-Baena, ZR; Arribas, JR; Berenguer, J; Carratala, J; Jarrin, I; Ryan, P; De Miguel-Montero, M; Rodriguez-Bano, J; Pachon, J.

( )Impact of early interferon-beta treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort

BIOMEDICINE & PHARMACOTHERAPY. 2022; 146: 112572-112572 Nº de citas: 9 [doi:10.1016/j.biopha.2021.112572]

Gottlieb, RL; Vaca, CE; Paredes, R; Mera, J; Webb, BJ; Perez, G; Oguchi, G; Ryan, P; Nielsen, BU; Brown, M; Hidalgo, A; Sachdeva, Y; Mittal, S; Osiyemi, O; Skarbinski, J; Juneja, K; Hyland, RH; Osinusi, A; Chen, S; Camus, G; Abdelghany, M; Davies, S; Behenna-Renton, N; Duff, F; Marty, FM; Katz, MJ; Ginde, AA; Brown, SM; Schiffer, JT; Hill, JA; GS-US-540-9012 PINETREE Investigat.

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

NEW ENGLAND JOURNAL OF MEDICINE. 2022; 386(4): 305-315 Nº de citas: 992 [doi:10.1056/NEJMoa2116846]